Stories

The IRE Resource Center is a major research library containing more than 27,000 investigative stories.

Most of our stories are not available for download but can be easily ordered by contacting the Resource Center directly at 573-882-3364 or rescntr@ire.org where a researcher can help you pinpoint what you need.

Search results for "Katherine Eban" ...

  • Bottle of Lies: The Inside Story of the Generic Drug Boom

    The widespread use of generic drugs has been hailed as one of the most important public health developments of the twenty-first century. Today, 90 percent of the U.S. pharmaceutical market is comprised of generic drugs, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Bottle of Lies: The Inside Story of the Generic Drug Boom exposes for the first time the endemic fraud behind generic drug manufacturing –and the attendant risks for global public health.The narrative investigation interweaves the stories of a determined whistleblower, an intrepid FDA investigator and drug manufacturers determined to deceive regulators. Reported on four continents over a ten-year period, and drawing on 20,000 pages of confidential FDA documents, the book uncovers how one of the world’s greatest public health innovations also became one of its most astonishing swindles. Bottle of Lies uncovers a global industry where companies routinely falsify quality data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects.
  • Ranbaxy

    Dirty Medicine is the inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans.
  • The Truth About the Fast and Furious Scandal

    When Republicans, Democrats, and the media agree that a series of events occurred, it must be true, right? That was the situation Katherine Eban faced when she began investigating the Fast and Furious scandal. As portrayed by congressional Republicans and conceded by a Democratic U.S. attorney general, the Bureau of Alcohol, Tobacco, Firearms, and Explosives had allegedly adopted a disastrous policy of intentionally allowing weapons to be illegally trafficked to Mexican drug lords. Those allegations were the basis for a major congressional investigation and a national scandal. They ultimately led to the first instance in U.S. history in which a cabinet member, Attorney General Eric Holder, was deemed in contempt of Congress (because he refused to turn over documents relating to Fast and Furious). But Eban’s reporting in “The Truth About the Fast and Furious Scandal” showed that, in fact, the ATF never had a policy to permit gun trafficking. Yes, weapons made their way to Mexico, but it occurred because of lax laws and prosecutors who interpreted those laws so strictly as to make gun seizures almost impossible. To uncover the truth, Eban combed through 2,000 pages of confidential ATF documents and interviewed 39 people, including seven agents involved in the case. In six months of exhaustive investigation, Eban persuaded the ATF agents at the heart of the case—including the leader of the team at issue, who had never spoken to the press before—to give their accounts. She then crafted a riveting narrative that exposed the hypocrisy of the political maneuverings around the business of selling and using guns. Most important, the article explained exactly why our system fails to stop weapons from being trafficked. Befitting the charged subject, Fortune’s article provoked an unprecedented wave of response on its website, national media attention, considerable fury from gun advocates—the FBI investigated threats made to Eban after the article appeared—and angry objections from figures who came in for criticism in the story. Rep. Darrell Issa and Sen. Charles Grassley, both leading figures in the congressional investigation, devoted a 49-page appendix to a congressional report, with an additional 140 pages of allegedly supporting documents, to try to rebut the story. And an ostensible ATF whistleblower whose allegations were challenged by Eban’s reporting filed suit against Fortune’s publisher. In the end, the best stories—and the ones that contradict a universally held view—often stir up the most anger.
  • Bad Bargain

    This article identifies several people who suffered consequences after switching from brand name drugs to generic ones. Furthermore, this article identifies loopholes that allow these generic drugs to reach the market. These generics, many of us believe are the same as the brand name ones, are actual substandard and un-equivalent.
  • The War on Terror: Rorschach and Awe

    The story revealed, for the first time, two psychologists who were "the architects and teachers of the coercive interrogation methods first used at the CIA's black sites, which then spread to Guantanamo and Abu Ghraib.”
  • Dangerous Doses: How Counterfeiters are Contaminating America's Drug Supply

    Eban writes about how medicine available from seemingly trustworthy sources like pharmacies and hospitals is sometimes not safe. The book shows how stolen, expired, mishandled or adulterated medicine cans still make their way into pharmacies and hospitals because they are passed through several other companies who buy and sell to one another. These companies sometimes have ties to drug traffickers and organized crime.
  • Pharmacy Fakes

    With this article, SELF Magazine broke the story of adulterated and counterfeit prescription drugs entering America's pharmacies. The article revealed for the first time, that counterfeiters had systematically infiltrated the domestic drug supply, gaining access to fragile medicines and diluting or falsely relabeling them in order to reap a high profit. They exposed how most of the nation's medicine passes through a vast gray market of wholesalers, and how weak enforcement of federal and state regulations makes it close to impossible to identify where our medicine has come from. The article contains personal accounts from patients who had been harmed by counterfeit medicine, and a report on a Florida investigation which had uncovered potential misconduct at 50 of the state's wholesale companies.
  • Medical Rebels

    Public discontent with corporate medicine continues to grow and healthcare professionals have been crossing the line into subtly and overtly illegal acts--from manipulation of the system and defiance of laws they deem unjust to fraud and threats of violence--in defense of their patients.
  • Deadly Morals

    The DEA is investigating doctors for perscribing drugs that are making the patients die in pain.